Search
STERIS plc
STEAdd to Watchlist
233.280USD
-2.770-1.17%
Close 08-14 16:00（ET）Quotes delayed by 15 min
22.74BMarket Cap
29.28P/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of STERIS plc is 7.64, ranking 127 out of 201 in the Healthcare Equipment & Supplies industry. The average price target is 293.00, with a high of 300.00 and a low of 231.81.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
265.988
Target Price
+14.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
STERIS plc
STE
12
Stryker Corp
SYK
30
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Zimmer Biomet Holdings Inc
ZBH
29
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is STERIS plc's expected revenue for the next quarter?
STERIS plc's expected revenue is 1.56B.
What is STERIS plc's price target?
Analysts forecast that STERIS plc's price target is USD 293.00, with the highest forecast at USD 300.00 and the lowest forecast at USD 231.81.
How have STERIS plcSTE's recent earnings per share performed?
The market expectation was USD 2.05, while STERIS plcSTE's earnings per share (EPS) for the previous quarter was USD 2.25. EPS for the next quarter is expected at USD 2.69.
What is the analyst rating for STERIS plc?
Based on the ratings of STERIS plc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.